Attached files
| file | filename |
|---|---|
| 10-K - HEMOBIOTECH, INC. | v186780_10k.htm |
| EX-4.3 - HEMOBIOTECH, INC. | v186780_ex4-3.htm |
| EX-31.1 - HEMOBIOTECH, INC. | v186780_ex31-1.htm |
| EX-31.2 - HEMOBIOTECH, INC. | v186780_ex31-2.htm |
| EX-32.2 - HEMOBIOTECH, INC. | v186780_ex32-2.htm |
| EX-10.22 - HEMOBIOTECH, INC. | v186780_ex10-22.htm |
Exhibit
32.1
CERTIFICATE
PURSUANT TO
18
U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Arthur
P. Bollon, Chief Executive Officer, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:
|
|
1.
|
The
Annual Report on Form 10-K for the year ended December 31, 2009 (the
"Report") fully complies with the requirements of section 13(a) or 15(d)
of the Securities Exchange Act of 1934;
and
|
|
|
2.
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of
HemoBioTech, Inc.
|
Dated:
May 26, 2010
|
By:
|
/s/
Arthur P. Bollon
|
||
|
Arthur
P. Bollon, Ph.D.
|
|||
|
President
and Chief Executive Officer
|